Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
about
APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriersProgression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.Abdominal Obesity Associated with Elevated Serum Butyrylcholinesterase Activity, Insulin Resistance and Reduced High Density Lipoprotein-Cholesterol Levels.Executive Dysfunction in MCI: Subtype or Early Symptom.Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.Haplotype-based association analysis of general cognitive ability in Generation Scotland, the English Longitudinal Study of Ageing, and UK Biobank.Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.Review of the Toxicology of Chlorpyrifos With an Emphasis on Human Exposure and Neurodevelopment
P2860
Q29416986-BB451939-39E8-4B0D-89D9-74714A0F4ECDQ33507730-DB8C8C78-7488-494A-B90E-32A0232C4EACQ33968308-2C390A4D-79DA-4686-807D-3B4A46568328Q34139700-1ED6984B-6DDD-4D34-8A28-CFD03E9893ADQ34804797-9D1953D0-5F28-46E9-A76A-8FC9FDC0D39FQ35747074-D464FEF7-F5B6-4195-BBA9-3ACC4EEAD479Q36014695-B9DF559B-9FCB-484F-8C05-281D0481CDD0Q36475090-C5B24C38-E589-4186-BB84-91F306894BEAQ37070395-7571452E-C325-4A23-9321-8F72CE185C57Q37104891-03049D25-B612-4E4A-9453-054A9F280DB7Q37297626-003D9FFE-E125-4EE9-A3B1-3B5FEAE7C18FQ37510386-CDC2D85F-8ADE-4E45-9295-3226158E4177Q37658872-9A2305F0-8993-46B1-8E8D-389FADE8CCF4Q42361174-E49BBD1F-811B-489A-B55A-93ADA673FA7EQ47288880-CC6A446A-564D-4016-B871-DBC3F39C2AB6Q47951730-19707116-C70E-4303-941A-20AC22079C5CQ50546601-3F038455-4F4C-4A03-8516-9A487F7F9C98Q56432121-D5B2835E-DCCE-4B26-A743-23CC173652FC
P2860
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Synergistic effect of apolipop ...... irment to Alzheimer's disease.
@en
Synergistic effect of apolipop ...... irment to Alzheimer's disease.
@nl
type
label
Synergistic effect of apolipop ...... irment to Alzheimer's disease.
@en
Synergistic effect of apolipop ...... irment to Alzheimer's disease.
@nl
prefLabel
Synergistic effect of apolipop ...... irment to Alzheimer's disease.
@en
Synergistic effect of apolipop ...... irment to Alzheimer's disease.
@nl
P2093
P50
P1476
Synergistic effect of apolipop ...... irment to Alzheimer's disease.
@en
P2093
Joanne Meyer
Martin R Farlow
Nigel H Greig
Nikolaos Sfikas
Roger Lane
Tuula Pirttilä
Yunsheng He
P304
P356
10.1097/FPC.0B013E3282F63F29
P577
2008-04-01T00:00:00Z